NasdaqCM - Nasdaq Real Time Price USD
Immix Biopharma, Inc. (IMMX)
As of 11:08 AM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
20,192.2770
16,141.1130
8,218.9480
1,352.0140
453.8520
Operating Income
-20,192.2770
-16,141.1130
-8,218.9480
-1,352.0140
-453.8520
Net Non Operating Interest Income Expense
990.0890
572.0060
-0.4970
-179.8530
-101.9760
Other Income Expense
--
--
--
-22,845.9990
-574.4880
Pretax Income
-19,202.1880
-15,569.1070
-8,219.4450
-24,377.8660
-1,130.3160
Tax Provision
34.0040
26.4150
10.2680
6.0130
17.5470
Net Income Common Stockholders
-19,022.0950
-15,426.0480
-8,229.7130
-24,383.8790
-1,147.8630
Diluted NI Available to Com Stockholders
-19,022.0950
-15,426.0480
-8,229.7130
-24,383.8790
-1,147.8630
Basic EPS
-0.83
-0.89
-0.59
-6.64
-0.13
Diluted EPS
-0.83
-0.89
-0.59
-6.64
-0.13
Basic Average Shares
23,641.2160
17,341.1460
13,887.3090
3,672.6110
8,774.8520
Diluted Average Shares
23,641.2160
17,341.1460
13,887.3090
3,672.6110
8,774.8520
Total Operating Income as Reported
-20,192.2770
-16,141.1130
-8,218.9480
-1,352.0140
-453.8520
Total Expenses
20,192.2770
16,141.1130
8,218.9480
1,352.0140
453.8520
Net Income from Continuing & Discontinued Operation
-19,022.0950
-15,426.0480
-8,229.7130
-24,383.8790
-1,147.8630
Normalized Income
-19,022.0950
-15,426.0480
-8,229.7130
-7,706.2997
-728.1130
Interest Income
990.0890
572.0060
--
--
--
Interest Expense
--
--
0.4970
179.8530
101.9760
Net Interest Income
990.0890
572.0060
-0.4970
-179.8530
-101.9760
EBIT
-19,620.2710
-15,569.1070
-8,218.9480
-24,198.0130
-1,028.3400
EBITDA
-19,567.6690
-15,563.6390
-8,216.8130
-24,195.5450
-1,026.0190
Reconciled Depreciation
52.6020
5.4680
2.1350
2.4680
2.3210
Net Income from Continuing Operation Net Minority Interest
-19,022.0950
-15,426.0480
-8,229.7130
-24,383.8790
-1,147.8630
Total Unusual Items Excluding Goodwill
--
--
--
-22,845.9990
-575.0000
Total Unusual Items
--
--
--
-22,845.9990
-575.0000
Normalized EBITDA
-19,567.6690
-15,563.6390
-8,216.8130
-1,349.5460
-451.0190
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
--
--
--
-6,168.4197
-155.2500
12/31/2020 - 12/16/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KTTA Pasithea Therapeutics Corp.
3.7200
-1.98%
ALXO ALX Oncology Holdings Inc.
1.4550
+1.75%
REVB Revelation Biosciences, Inc.
0.8450
-0.94%
MAIA MAIA Biotechnology, Inc.
2.8000
+0.72%
ELTX Elicio Therapeutics, Inc.
4.4000
+3.29%
KYTX Kyverna Therapeutics, Inc.
4.8200
+0.84%
VCNX Vaccinex, Inc.
2.9300
+5.02%
INAB IN8bio, Inc.
0.2948
+5.21%
CHRO Chromocell Therapeutics Corporation
0.6275
+1.16%
DRMA Dermata Therapeutics, Inc.
1.3100
+3.15%